Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | THPO | P40225 | 1/20 | 0.32 |
| ▸ | ATP1A1 | P05023 | 1/20 | 0.30 |
| ▸ | ATP1B1 | P05026 | 1/20 | 0.30 |
| ▸ | ATP1A3 | P13637 | 1/20 | 0.30 |
| ▸ | ATP1B2 | P14415 | 1/20 | 0.30 |
| ▸ | ATP1A2 | P50993 | 1/20 | 0.30 |
| ▸ | ATP1B3 | P54709 | 1/20 | 0.30 |
| ▸ | FXYD2 | P54710 | 1/20 | 0.30 |
| ▸ | ATP1A4 | Q13733 | 1/20 | 0.30 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pemerid SCHEMBL636223 | 0.89 | — | — | |
| SCHEMBL11152233 | 0.81 | NPC1 (0.30) | — | |
| SCHEMBL11168513 | 0.80 | EPHX2 (0.31) | — | |
| SCHEMBL13645697 | 0.79 | — | — | |
| SCHEMBL13202047 | 0.78 | — | — | |
| SCHEMBL20448608 | 0.77 | LMNA (0.32) | LMNACYP1A2THPO | |
| SCHEMBL19937169 | 0.77 | — | — | |
| SCHEMBL4347877 | 0.77 | GBA1 (0.39) | — | |
| SCHEMBL11174237 | 0.77 | GBA1 (0.39) | — | |
| SCHEMBL22371937 | 0.77 | GBA1 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103877169-B | A kind of compositions for the treatment of cough | SUN HUA (CN) | 2016-01-06 | — | — | CN | claimed |
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| CN-103877169-A | Composition for treating cough | SUN HUA | 2014-06-25 | — | — | CN | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| US-6608073-B1 | Rapidly and reliably delivering codeine to systemic circulation of patient for prevention or treatment of pain or cough | NEW MILLENNIUM PHARMACEUTICAL RESEARCH, INC. | 2003-08-19 | — | — | US | claimed |
| WO-2000021515-A9 | INTRANASAL CODEINE FOR THE RAPID SUPPRESSION OF COUGH AND RAPID RELIEF OF PAIN | NEW MILLENNIUM PHARMACEUTICAL (US) | 2001-03-29 | — | — | WO | claimed |
| WO-2000021515-A2 | INTRANASAL CODEINE FOR THE RAPID SUPPRESSION OF COUGH AND RAPID RELIEF OF PAIN | NEW MILLENNIUM PHARMACEUTICAL RESEARCH, INC. (US) | 2000-04-20 | — | — | WO | claimed |
| CN-115087665-A | Engineered platelets for targeted delivery of therapeutic agents | JPV01有限公司 | 2022-09-20 | — | — | CN | disclosed |
| CN-114209689-A | Method for treating chronic kidney disease with dapagliflozin | 阿斯利康(瑞典)有限公司 | 2022-03-22 | — | — | CN | disclosed |
| US-20220047505-A1 | Controlled Absorption Water-Soluble Pharmaceutically Active Organic Compound Formulation for Once-Daily Administration | STI PHARMA, LLC (US) | 2022-02-17 | — | — | US | disclosed |
| US-11191719-B2 | Controlled absorption water-soluble pharmaceutically active organic compound formulation for once-daily administration | STI PHARMA, LLC (US) | 2021-12-07 | — | — | US | disclosed |
| US-10463611-B2 | Controlled absorption water-soluble pharmaceutically active organic compound formulation for once-daily administration | STI PHARMA, LLC (US) | 2019-11-05 | — | — | US | disclosed |
| US-6331289-B1 | ULTRASOUND CONTRAST AGENTS, SUSPENSION IN AQUEOUS CARRIER LIQUID OF A REPORTER COMPRISING GAS-CONTAINING OR GAS-GENERATING MATERIAL, AGENT CAPABLE OF FORMING AT LEAST TWO TYPES OF BINDING PAIRS WITH TARGET; REPORTER BEING CONJUGATED | NYCOMED IMAGING AS (NO) | 2001-12-18 | — | — | US | disclosed |
| US-6264917-B1 | MIXTURE OF GAS FILLED MICROBUBBLES AND RELEASING AGENT | NYCOMED IMAGING AS (NO) | 2001-07-24 | — | — | US | disclosed |
| US-6261537-B1 | TARGETS AND ULTRASOUND DIAGNOSIS OF ACTIVE MATERIALS, AQUEOUS CARRIER LIQUIDS, CARRIERS AND FILM FORMING SURFACTANT PHOSPHATIDES | NYCOMED IMAGING AS (NO) | 2001-07-17 | — | — | US | disclosed |
| WO-2000021515-A9 | INTRANASAL CODEINE FOR THE RAPID SUPPRESSION OF COUGH AND RAPID RELIEF OF PAIN | NEW MILLENNIUM PHARMACEUTICAL (US) | 2001-03-29 | — | — | WO | disclosed |
| WO-2000021515-A2 | INTRANASAL CODEINE FOR THE RAPID SUPPRESSION OF COUGH AND RAPID RELIEF OF PAIN | NEW MILLENNIUM PHARMACEUTICAL RESEARCH, INC. (US) | 2000-04-20 | — | — | WO | disclosed |